Product Images Ondansetron
View Photos of Packaging, Labels & Appearance
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 - ondansetronod fig1
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig2
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (30 Tablets Bottle) - ondansetronod fig3
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig4
- Chemical Structure - ondansetronod str
Product Label Images
The following 5 images provide visual information about the product associated with Ondansetron NDC 67296-1321 by Redpharm Drug, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 - ondansetronod fig1
This text is a prescription label for Ondansetron Orally Disintegrating Tablets, USP manufactured by AUROBINDO. It includes information on the dosage, storage conditions, and distribution details, as well as a cautionary note about not removing the tablet from the blister pack until immediately before use. The tablets meet the USP Disintegration Test 2 and should be dispensed in a tightly closed, light-resistant container as per USP guidelines.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig2
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (30 Tablets Bottle) - ondansetronod fig3
This is a description for Ondansetron Orally Disintegrating Tablets, USP by AUROBINDO. Each orally disintegrating tablet contains Ondansetron USP 8 mg. The tablets are recommended for the treatment of nausea and vomiting. It is essential to follow the recommended dosage and administration instructions provided in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F). They should be dispensed in a tight, light-resistant container. This medication meets USP Disintegration Test 2 standards. Distributed by Aurobindo Pharma USA, it is made in India.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig4
This text is a description of Ondansetron Orally Disintegrating Tablets, USP manufactured by AUROBINDO. The tablets contain USP and are intended for oral consumption. Each package consists of 30 tablets divided into 3 blister cards with 10 tablets each. It provides dosage and administration instructions and warns against removing the tablets from the blister pack until immediately before use. The product should be stored between 20°C to 25°C. The text also includes distribution information for Aurobindo Pharma USA, based in East Windsor, NJ.*
Chemical Structure - ondansetronod str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
